HAGEN BRETT R (Chief Accounting Officer) sold 32.0% of their position (907.00 shares) of KALARIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $8.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/27/2025ACC: 0000950170-25-046263
Officer· Chief Accounting Officer
Since Jul 2020
-907.00
Net shares
Net seller
$8.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
907.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−907.00
Price / share
$8.97
Trade value
$8.14K
% of position
32.0%
3/26/2025
2.83K→1.93K
Total
Net shares
−907.00
Net value
-$8.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2025 | S · Sale | −907.00 | $8.97 | $8.14K | 32.0% | 2.83K | 1.93K |
| Total | −907.00 | -$8.14K | ||||||
Derivative Transactions0
No derivative transactions reported